Can the published cost analysis data for delivery of an efficient primary angioplasty service be applied to the modern National Health Service?

Heart

Volumn 91, Issue 10, 2005, Pages 1262-1264

  Melikian, N ^a,b   Morgan, K P ^a   Beatt, K J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; STREPTOKINASE;

CORONARY STENT; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; FIBRINOLYTIC THERAPY; HEALTH CARE COST; HEALTH SERVICE; HEART INFARCTION; HUMAN; MEDICAL LITERATURE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REPERFUSION; REVIEW; ARTICLE; COST; ECONOMICS; EUROPE; FORECASTING; NATIONAL HEALTH SERVICE; NORTH AMERICA; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED KINGDOM;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COSTS AND COST ANALYSIS; EUROPE; FORECASTING; GREAT BRITAIN; HUMANS; MYOCARDIAL INFARCTION; NORTH AMERICA; STATE MEDICINE;

EID: 25144450142     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.059402     Document Type: Review

References (9)

1. The National Service Framework for coronary heart disease - winning the war on heart disease. Progress report 2004.
2. De Boer MJ, van Hout BA, Liem AL, et al. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Am J Card 1995;76:830-3.
3. Suryapranata H, Ottervanger JP, Nibbering E, et al. Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction. Heart 2001;85:667-71.
4. Van't Hof AW, Suryapranata H, de Boer MJ, et al. Costs of stenting for acute myocardial infarction. Lancet 1998;351:1817.
5. Reeder GS, Bailey KR, Gersh BJ, et al. Cost comparison of immediate angioplasty versus thrombolysis followed by conservative therapy for acute myocardial infarction: a randomised prospective trial. Mayo Clin Proc 1994;69:5-12.
6. Stone GW, Grines CL, Rothbaum D, et al. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the primary angioplasty in myocardial infarction (PAMI) trial. J Am Coll Cardiol 1997;29:901-7.
7. Le May MR, Davies RF, Labinaz M, et al. Hopsitalization costs of primary stenting versus thrombolysis in acute myocardial infarction - cost analysis of the Canadian STAT study. Circulation 2003;108:2624-30.
8. Lieu TA, Gurley RJ, Lundstrom RJ, et al. Projected cost-effectiveness of primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1997;30:1741-50.
9. Parmley WW. Cost-effectiveness of reperfusion strategies. Am Heart J 1999;138:S142-6.